Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Comparison of Prognostic Impact of Atezolizumab Plus Bevacizumab Versus Lenvatinib in Patients with Intermediate-Stage Hepatocellular Carcinoma

Toshifumi Tada,Takashi Kumada,Atsushi Hiraoka,Masashi Hirooka,Kazuya Kariyama,Joji Tani,Masanori Atsukawa,Koichi Takaguchi,Ei Itobayashi,Shinya Fukunishi,Kunihiko Tsuji,Toru Ishikawa,Kazuto Tajiri,Hironori Ochi,Satoshi Yasuda,Hidenori Toyoda,Chikara Ogawa,Takashi Nishimura,Takeshi Hatanaka,Satoru Kakizaki,Noritomo Shimada,Kazuhito Kawata,Fujimasa Tada,Hideko Ohama,Kazuhiro Nouso,Asahiro Morishita,Akemi Tsutsui,Takuya Nagano,Norio Itokawa,Tomomi Okubo,Taeang Arai,Michitaka Imai,Hisashi Kosaka,Atsushi Naganuma,Tomomitsu Matono,Tomoko Aoki,Hidekatsu Kuroda,Yutaka Yata,Yohei Koizumi,Shinichiro Nakamura,Masaki Kaibori,Hiroko Iijima,Yoichi Hiasa,Masatoshi Kudo

LIVER INTERNATIONAL（2024）

Cited 0|Views63
No score
Key words
atezolizumab plus bevacizumab,hepatocellular carcinoma,intermediate stage,lenvatinib,survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined